University of Wisconsin Foundation

In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), University of Wisconsin Foundation reported 6 stock positions worth $88.8 million. Its top holding was iShares Core S&P 500 ETF (IVV) at 34.7% of the portfolio, followed by Nu Holdings Ltd./Cayman Isl-A (NU, 20.8%) and Madrigal Pharmaceuticals (MDGL, 14.4%). Compared with Q1 2024, it added to 3 and reduced 1. The biggest buy was iShares Core S&P 500 ETF (IVV, shares +2%) and the biggest sale Madrigal Pharmaceuticals (MDGL, shares −19%).

Most Recent 13F
Q2 2026
Location
MADISON, WI
CIK
0001697228
Portfolio Value
$88.8M (Q2 2024)
SEC Filing
0001697228-24-000008 ↗ filed Aug 14, 2024

Holdings Value

0$50.0M$100.0M$150.0M$200.0M Q1 2024: $88.6M Q1 2024 Q2 2024: $88.8M $88.8M Q2 2024 Q3 2024: $153.3M Q3 2024 Q4 2024: $137.6M Q4 2024 Q1 2025: $117.8M Q1 2025 Q2 2025: $89.4M Q2 2025 Q3 2025: $118.1M Q3 2025 Q4 2025: $118.9M Q4 2025 Q1 2026: $112.6M Q1 2026 Q2 2026: $126.3M Q2 2026

Holdings 6 stocks · $88.8M

IVV iShares Core S&P 500 ETF 34.71% 56,348 $30.8M Add +1.6%
NU Nu Holdings Ltd./Cayman Isl-A filed as NU HLDGS LTD 20.78% 1,431,951 $18.5M No change
MDGL Madrigal Pharmaceuticals Inc. 14.42% 45,730 $12.8M Reduce -18.9%
GE General Electric filed as GE AEROSPACE 12.36% 69,083 $11.0M No change
AKRO Akero Therapeutics Inc. 11.19% 423,849 $9.9M Add +13.8%
ETNB 89BIO Inc. 6.53% 724,132 $5.8M Add +45.4%

Portfolio Sells Q1 2024 → Q2 2024

MDGL Madrigal Pharmaceuticals Inc. Reduce -18.9% 14.42% −2.56

Portfolio Buys Q1 2024 → Q2 2024

IVV iShares Core S&P 500 ETF Add +1.6% 34.71% +1.82
AKRO Akero Therapeutics Inc. Add +13.8% 11.19% +0.57
ETNB 89BIO Inc. Add +45.4% 6.53% −0.01

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 9$126.3MSMH, CBRS, PDCC, PCVX, NU
Q1 2026 10$112.6MPDCC, NU, PCVX, AAPL, SE
Q4 2025 8$118.9MNU, PDCC, AAPL, NVDA, MSFT
Q3 2025 9$118.1MPDCC, NU, AKRO, RNAM, NVDA
Q2 2025 5$89.4MPDCC, NU, AKRO, MDGL, ETNB
Q1 2025 8$117.8MSE, PDCC, MDGL, NU, AKRO
Q4 2024 7$137.6MSE, PDCC, IVV, NU, MDGL
Q3 2024 7$153.3MSE, IVV, PDCC, NU, AKRO
Q2 2024 6$88.8MIVV, NU, MDGL, GE, AKRO
Q1 2024 6$88.6MIVV, NU, MDGL, GE, AKRO